- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 111.89M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $122.85K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.8M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.75M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.22M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.2M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $47.25M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $9.93M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $132.57M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $95.35M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 87.4M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$10.19M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.25M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$8.79M |